Abstract
The article represents data of the development and evaluation of the effectiveness of complex therapy of adaptation disorders using the drug Alora. A comprehensive examination of 154 patients with maladaptation disorders (F43.2) was held, both sexes, aged 20—55 years. Basing on the results of the clinical-psychopathological methods, which were based on generally accepted approaches to psychiatric examination through interviews and observations, the high efficacy and good tolerability of Alora (passiflora incarnata extract) in the treatment of adaptation disorders has been proven. Against the background of the use of the drug Alora there is a rapid reduction of anxiety and depressive symptoms, normalization of the sleep-wake cycle, reduction of the level of nervous and mental stress, restoring efficiency and social activity, improvement of the quality of life of the subjects. The data obtained should be taken into account as diagnostic and preventive measures in the care of this category of patients
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
